Mereo BioPharma (MREO) Share-based Compensation (2023 - 2026)
Mereo BioPharma (MREO) recorded Share-based Compensation of $1.32 million in Q2 2026, down 36.2% from $2.07 million a year earlier and down 17.9% from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Share-based Compensation (2023 - 2026) Analysis & Trends
On a TTM basis, Mereo BioPharma's Share-based Compensation came in at $6.18 million as of Jun 30, 2026, down 18.7% year-over-year; for FY2025, it was $7.6 million, up 2.8% from FY2024.
- Annual Share-based Compensation has increased for five straight years, with a five-year compound annual growth rate of 29.9% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $7.39 million in FY2024 (+50.1%), $4.92 million in FY2023 (+3.3%), $4.77 million in FY2022 (+7.1%) and $4.45 million in FY2021 (+116.4%).
- The Q2 2026 figure is the lowest quarterly Share-based Compensation since Q4 2023.
- On a year-over-year basis, Share-based Compensation rose in four of the last eight quarters, with growth averaging 5.5%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 121.4% in Q2 2024, against a decline of 36.2% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.61 million (Q1 2026), $1.54 million (Q4 2025) and $1.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,129.39 Bn | 1,097.98 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 615.68 Bn | 534.21 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 505.77 Bn | 478.89 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.50 Bn | 320.88 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.33 Bn | 261.32 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.02 Bn | 234.71 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.47 Bn | 190.87 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 189.20 Bn | 163.40 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.20 Bn | 116.85 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Mereo BioPharma | 48.34 Mn | -101.57 Mn | - | 1.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.32 Mn |
| Mar 31, 2026 | 1.61 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | 2.28 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 2.09 Mn |
| Mar 31, 2024 | 2.05 Mn |
| Dec 31, 2023 | 815,000.00 |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 943,000.00 |
| Mar 31, 2023 | 1.64 Mn |
API Access
Mereo BioPharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();